What are the latest clinical guidelines for tapering off long term prescription sleep aids that are among the standard FDA approved insomnia medications without causing severe rebound insomnia?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the latest clinical guidelines for tapering off long term prescription sleep aids that are among the standard FDA approved insomnia medications without causing severe rebound insomnia?
3 real searches · 1 real-search pass
2025 2026 clinical guideline deprescribing taper long term insomnia medications benzodiazepines Z-drugs rebound insomnia CBT-I guidelineGoogle ↗
OBSERVED
Alliance for Sleep clinical practice guideline switching deprescribing hypnotic medications taper zolpidem eszopiclone suvorexant ramelteon doxepinGoogle ↗
OBSERVED
FDA prescribing information insomnia medications discontinuation rebound insomnia benzodiazepines zolpidem eszopiclone zaleplonGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2025 2026 clinical guideline deprescribing taper long term insomnia medications benzodiazepines Z-drugs rebound insomnia CBT-I guideline Google ↗
Alliance for Sleep clinical practice guideline switching deprescribing hypnotic medications taper zolpidem eszopiclone suvorexant ramelteon doxepin Google ↗
FDA prescribing information insomnia medications discontinuation rebound insomnia benzodiazepines zolpidem eszopiclone zaleplon Google ↗
- Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia · pmc.ncbi.nlm.nih.gov
- Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: Results of European neuropsychopharmacology and sleep expert's consensus group · pubmed.ncbi.nlm.nih.gov
- Recommendations on Switching or Deprescribing Hypnotic Medications for Insomnia (18.09.2026) · doi.org
- Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: Results of European neuropsychopharmacology and sleep expert's consensus group · sciencedirect.com
- Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits · pmc.ncbi.nlm.nih.gov
- The Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea (Insomnia/OSA) (2025) · healthquality.va.gov
- Benzodiazepine Tapering · asam.org
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2025 2026 clinical guideline deprescribing taper long term insomnia medications benzodiazepines Z-drugs rebound insomnia CBT-I guideline OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
Alliance for Sleep clinical practice guideline switching deprescribing hypnotic medications taper zolpidem eszopiclone suvorexant ramelteon doxepin OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA prescribing information insomnia medications discontinuation rebound insomnia benzodiazepines zolpidem eszopiclone zaleplon OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |